Purpose: To evaluate the safety, efficacy, predictability, and visual results of laser in situ keratomileusis (LASIK) using the Bausch & Lomb Technolas 217 for the treatment of compound MYOPIC ASTIGMATISM.Setting: Standard LASIK center, Nemazi Hospital, Shiraz, IRAN.Methods: In a prospective study, 60 eyes of 37 MYOPIC astigmatic patients with a mean pre-op spherical equivalent (SE) of -5.6 diopters (0) :!:2.15(SO) (range -2.37 to- 13.5 0) and mean pre-op ASTIGMATISM of -2.27 0 (range -1 to -6 0) underwent LASIK using the Technolas 217 system. The patients were followed 1 day, 1 week, 1 month, 3 months and 6 months after the procedure.Results: Mean SE refraction reduced significantly, 91% reduction at 1st wk (-0.52 0), 90% reduction at 1st month (-0.59 0), 89% reduction at 3rd month (-0.63 0) and 85% at 6th month (-0.87 0). Mean pre-op ASTIGMATISM (-2.27 0) reduced, too. At first wk 77% reduction (mean=-0.520), at 1st month 71% reduction (mean=-0.65 0), at 3rd month 68% reduction (mean=-0.72 0), and at 6th month 60% reduction (mean = -0.92 0).Pre-op best corrected visual acuity (BCVA) of 10/10 was seen in 55% of patients that increased post operatively to 72% at 6 months.Post-op uncorrected visual acuity (UCVA) was 10/10 or better, in 43% at 1st wk, in 45% at 1st month, in 55% at 3rd month, and in 48% at 6th month.Post-op decrease in BCVA (1or 2 lines) was seen in 4 eyes (6%), but no decrease in BCVA more than 2 lines was seen in any eye.Conclusion: The Technolas 217 system yielded acceptable post-pp UCVA and BCVA.lt is safe and effective in treatment of MYOPIC ASTIGMATISM. But long term follow-up is needed to assess stability of the procedure.